{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:39:09Z","timestamp":1792701549419,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-05816-0","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:03:00Z","timestamp":1770660180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT)"],"prefix":"10.1186","volume":"25","author":[{"given":"Sebastian","family":"Hachizovu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Manyando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nambozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shepherd","family":"Khondowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busiku","family":"Hamainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Mukumbuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Rietveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mukomena Sompwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislain","family":"Kikunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hypolite","family":"Muhindo-Mavoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flory","family":"Luzolo Khote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Kanyamukenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Bastiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9","family":"Kakudji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tafadzwa","family":"Maseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geofrey","family":"Makenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Baraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Mutombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Duparc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Van Geertruyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"5816_CR1","unstructured":"World malaria report, 2024."},{"key":"5816_CR2","unstructured":"World malaria report, 2023."},{"issue":"1","key":"5816_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tmi.12313_2","volume":"19","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Severe malaria. Trop Med Int Health. 2014;19(1):1\u2013131. https:\/\/doi.org\/10.1111\/tmi.12313_2.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"5816_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04301-8","volume":"6","author":"NJ White","year":"2022","unstructured":"White NJ. Severe malaria. Malar J. 2022;6(1):284. https:\/\/doi.org\/10.1186\/s12936-022-04301-8.","journal-title":"Malar J"},{"issue":"9","key":"5816_CR5","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s00436-020-06786-1","volume":"119","author":"JO Adebayo","year":"2020","unstructured":"Adebayo JO, Tijjani H, Adegunloye AP, Ishola AA, Balogun EA, Malomo SO. Enhancing the antimalarial activity of artesunate. Parasitol Res. 2020;119(9):2749\u201364.","journal-title":"Parasitol Res"},{"key":"5816_CR6","unstructured":"World Health Organization. Guidelines for the treatment of malaria, 3rd ed. World Health Organization. 2015. https:\/\/iris.who.int\/handle\/10665\/162441"},{"key":"5816_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02223-20","author":"C Fanello","year":"2021","unstructured":"Fanello C, Hoglund RM, Lee SJ, Kayembe D, Ndjowo P, Kabedi C, et al. Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa. Antimicrob Agents Chemother. 2021. https:\/\/doi.org\/10.1128\/AAC.02223-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"5816_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2471\/BLT.19.231506","volume":"97","author":"C Green","year":"2019","unstructured":"Green C, Quigley P, Kureya T, Barber C, Chizema E, Moonga H, et al. Use of rectal artesunate for severe malaria at the community level, Zambia. Bull World Health Organ. 2019;97(12):810\u20137.","journal-title":"Bull World Health Organ"},{"key":"5816_CR9","unstructured":"World Health Organization, The use of rectal artesunate as a pre-referral treatment for severe P. falciparum malaria, Information note. 2022."},{"issue":"9","key":"5816_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgph.0000464","volume":"2","author":"C Lengeler","year":"2022","unstructured":"Lengeler C, Burri C, Awor P, Athieno P, Kimera J, Tumukunde G, et al. Community access to rectal artesunate for malaria (CARAMAL): a large-scale observational implementation study in the Democratic Republic of the Congo, Nigeria and Uganda. PLOS Glob Public Heal. 2022;2(9):1\u201326. https:\/\/doi.org\/10.1371\/journal.pgph.0000464.","journal-title":"PLOS Glob Public Heal"},{"key":"5816_CR11","unstructured":"World Health Organization, The use of rectal artesunate as a pre-referral treatment for severe P. falciparum malaria, Update. 2023."},{"issue":"1","key":"5816_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02541-8","volume":"20","author":"MW Hetzel","year":"2022","unstructured":"Hetzel MW, Okitawutshu J, Tshefu A, Omoluabi E, Awor P, Signorell A, et al. Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational study. BMC Med. 2022;20(1):343. https:\/\/doi.org\/10.1186\/s12916-022-02541-8.","journal-title":"BMC Med"},{"key":"5816_CR13","unstructured":"National Malaria Elimination Centre, Zambia, Integrated Community Case Management (iCCM) Community Malaria Case Management, Surveillance and Treatment of Diarrhoea, Pneumonia and Malnutrition in under-five children Facilitator\u2019s Handbook 5th Edition. 2023."},{"key":"5816_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6753","author":"DH Peters","year":"2013","unstructured":"Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Implementation research: what it is and how to do it. BMJ. 2013. https:\/\/doi.org\/10.1136\/bmj.f6753.","journal-title":"BMJ"},{"key":"5816_CR15","unstructured":"Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: report of a virtual meeting, 17\u201318 May 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"2","key":"5816_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","volume":"13","author":"NA Patsopoulos","year":"2011","unstructured":"Patsopoulos NA. A pragmatic view on pragmatic trials. Dialog Clin Neurosci. 2011;13(2):217\u201324.","journal-title":"Dialog Clin Neurosci"},{"issue":"3","key":"5816_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217\u201326. https:\/\/doi.org\/10.1097\/MLR.0b013e3182408812.","journal-title":"Med Care"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05816-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05816-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05816-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:01:57Z","timestamp":1772564517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05816-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5816"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05816-0","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original protocol and its amendment were approved by the National Health Research Ethics Board in Zambia (reference number NHREB001\/15\/04\/2024 and Ref No: NHRA-2221\/13\/05\/2025) and the Comit\u00e9 National d\u2019Ethique de la Sant\u00e9 in the Democratic Republic of Congo (reference number 502\/CNES\/BN\/PMMF\/2023 and 668\/CNES\/BN\/PMMF\/2025). The protocol was also approved by the Zambia Medicines Regulatory Authority in Zambia. The study is registered at ClinicalTrials.gov (identifier NCT06806956).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}